Skip to main content
Annals of Intensive Care
Fig. 2 | Annals of Intensive Care

Fig. 2

From: Impact of dexamethasone on the incidence of ventilator-associated pneumonia and blood stream infections in COVID-19 patients requiring invasive mechanical ventilation: a multicenter retrospective study

Fig. 2

Estimated cumulative incidence of the first episode of ventilator-associated pneumonia (VAP) according to dexamethasone treatment, taking into account death, extubation and the use of rescue immunosuppressive therapy (RIT) as competing events. p values for differences between dexamethasone and no dexamethasone patients were 0.59 for VAP, 0.3 for death 0.94 for extubation and 0.61 for RIT. DEXA+: patients treated with dexamethasone, DEXA−: patients not treated with dexamethasone, VAP: ventilator-associated pneumonia

Back to article page